These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

996 related articles for article (PubMed ID: 33493353)

  • 1. Delineating phenotypes of Kawasaki disease and SARS-CoV-2-related inflammatory multisystem syndrome: a French study and literature review.
    Cherqaoui B; Koné-Paut I; Yager H; Bourgeois FL; Piram M
    Rheumatology (Oxford); 2021 Oct; 60(10):4530-4537. PubMed ID: 33493353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey.
    Cattalini M; Della Paolera S; Zunica F; Bracaglia C; Giangreco M; Verdoni L; Meini A; Sottile R; Caorsi R; Zuccotti G; Fabi M; Montin D; Meneghel A; Consolaro A; Dellepiane RM; Maggio MC; La Torre F; Marchesi A; Simonini G; Villani A; Cimaz R; Ravelli A; Taddio A;
    Pediatr Rheumatol Online J; 2021 Mar; 19(1):29. PubMed ID: 33726806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2.
    Whittaker E; Bamford A; Kenny J; Kaforou M; Jones CE; Shah P; Ramnarayan P; Fraisse A; Miller O; Davies P; Kucera F; Brierley J; McDougall M; Carter M; Tremoulet A; Shimizu C; Herberg J; Burns JC; Lyall H; Levin M;
    JAMA; 2020 Jul; 324(3):259-269. PubMed ID: 32511692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype, Susceptibility, Autoimmunity, and Immunotherapy Between Kawasaki Disease and Coronavirus Disease-19 Associated Multisystem Inflammatory Syndrome in Children.
    Chen MR; Kuo HC; Lee YJ; Chi H; Li SC; Lee HC; Yang KD
    Front Immunol; 2021; 12():632890. PubMed ID: 33732254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing between typical Kawasaki disease and multisystem inflammatory syndrome in children (MIS-C) associated with SARS-CoV-2.
    Yeo WS; Ng QX
    Med Hypotheses; 2020 Nov; 144():110263. PubMed ID: 33254568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac pathology and outcomes vary between Kawasaki disease and PIMS-TS.
    Felsenstein S; Duong P; Lane S; Jones C; Pain CE; Hedrich CM
    Clin Immunol; 2021 Aug; 229():108780. PubMed ID: 34118400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [SARS-CoV-2-associated inflammatory multisystem disease in a 15-year-old boy].
    Ormay C; Onozó B; Fitala R; Halász K; Szakos E; Kosztopulosz N; Hauser P
    Orv Hetil; 2021 Apr; 162(16):602-607. PubMed ID: 33830937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological and Clinical Profile of Pediatric Inflammatory Multisystem Syndrome - Temporally Associated with SARS-CoV-2 (PIMS-TS) in Indian Children.
    Dhanalakshmi K; Venkataraman A; Balasubramanian S; Madhusudan M; Amperayani S; Putilibai S; Sadasivam K; Ramachandran B; Ramanan AV
    Indian Pediatr; 2020 Nov; 57(11):1010-1014. PubMed ID: 32769230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kawasaki disease versus Multisystem Inflammatory Syndrome COVID-19 with Kawasaki disease phenotype. Single-center experience].
    Peña Bustos L; Oviedo Sarmiento C; Carolina Rivacoba M; Arriagada Mora MJ; Veloso Stiiven F; Zambrano Ostaiza P
    Andes Pediatr; 2024 Apr; 95(2):174-182. PubMed ID: 38801365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management.
    Kabeerdoss J; Pilania RK; Karkhele R; Kumar TS; Danda D; Singh S
    Rheumatol Int; 2021 Jan; 41(1):19-32. PubMed ID: 33219837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric Inflammatory Multisystem Syndrome: Temporally Associated with SARS-CoV-2 (PIMS-TS): Cardiac Features, Management and Short-Term Outcomes at a UK Tertiary Paediatric Hospital.
    Ramcharan T; Nolan O; Lai CY; Prabhu N; Krishnamurthy R; Richter AG; Jyothish D; Kanthimathinathan HK; Welch SB; Hackett S; Al-Abadi E; Scholefield BR; Chikermane A
    Pediatr Cardiol; 2020 Oct; 41(7):1391-1401. PubMed ID: 32529358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and differences between multiple inflammatory syndrome in children associated with COVID-19 and Kawasaki disease: clinical presentations, diagnosis, and treatment.
    Zhang QY; Xu BW; Du JB
    World J Pediatr; 2021 Aug; 17(4):335-340. PubMed ID: 34013488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of severe hyperinflammation in the COVID-19 era: the role of the rheumatologist.
    Papadopoulou C; Al Obaidi M; Moraitis E; Compeyrot-Lacassagne S; Eleftheriou D; Brogan P
    Rheumatology (Oxford); 2021 Feb; 60(2):911-917. PubMed ID: 33197261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.
    Lee PY; Day-Lewis M; Henderson LA; Friedman KG; Lo J; Roberts JE; Lo MS; Platt CD; Chou J; Hoyt KJ; Baker AL; Banzon TM; Chang MH; Cohen E; de Ferranti SD; Dionne A; Habiballah S; Halyabar O; Hausmann JS; Hazen MM; Janssen E; Meidan E; Nelson RW; Nguyen AA; Sundel RP; Dedeoglu F; Nigrovic PA; Newburger JW; Son MBF
    J Clin Invest; 2020 Nov; 130(11):5942-5950. PubMed ID: 32701511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units.
    Hékimian G; Kerneis M; Zeitouni M; Cohen-Aubart F; Chommeloux J; Bréchot N; Mathian A; Lebreton G; Schmidt M; Hié M; Silvain J; Pineton de Chambrun M; Haroche J; Burrel S; Marot S; Luyt CE; Leprince P; Amoura Z; Montalescot G; Redheuil A; Combes A
    Chest; 2021 Feb; 159(2):657-662. PubMed ID: 32910974
    [No Abstract]   [Full Text] [Related]  

  • 16. Multisystem inflammatory syndrome (MIS-C) in Pakistani children: A description of the phenotypes and comparison with historical cohorts of children with Kawasaki disease and myocarditis.
    Mohsin SS; Abbas Q; Chowdhary D; Khalid F; Sheikh AS; Ali Khan ZG; Aslam N; Bhatti OA; Inam M; Saleem AF; Bhutta AT
    PLoS One; 2021; 16(6):e0253625. PubMed ID: 34153080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe acute respiratory syndrome coronavirus 2-related multisystem inflammatory syndrome in children mimicking Kawasaki disease.
    Mercier JC; Ouldali N; Melki I; Basmaci R; Levy M; Titomanlio L; Beyler C; Meinzer U
    Arch Cardiovasc Dis; 2021 May; 114(5):426-433. PubMed ID: 34052147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C.
    Zhu YP; Shamie I; Lee JC; Nowell CJ; Peng W; Angulo S; Le LN; Liu Y; Miao H; Xiong H; Pena CJ; Moreno E; Griffis E; Labou SG; Franco A; Broderick L; Hoffman HM; Shimizu C; Lewis NE; Kanegaye JT; Tremoulet AH; Burns JC; Croker BA;
    J Clin Invest; 2021 Oct; 131(20):. PubMed ID: 34464357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of early characteristics of multisystemic inflammatory syndrome and Kawasaki disease in children and the course of Kawasaki disease in the pandemic.
    Alkan F; Bircan O; Bal A; Bayturan S; Zengin N; Coskun S
    BMC Pediatr; 2024 Jul; 24(1):485. PubMed ID: 39080588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.